Developing Memory Reconsolidation Blockers as Novel PTSD Treatments

Trial Profile

Developing Memory Reconsolidation Blockers as Novel PTSD Treatments

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs Mifepristone (Primary) ; Cycloserine
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jul 2012 Additional trial investigator identified as reported by ClinicalTrials.gov.
    • 02 Jul 2012 Planned End Date changed from 1 Jul 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top